Location History:
- Carmel, IN (US) (2017 - 2018)
- Indianapolis, IN (US) (2018 - 2022)
Company Filing History:
Years Active: 2017-2022
Title: Christopher C Stowers: Innovator in Microbial Metabolic Pathways
Introduction
Christopher C Stowers is a prominent inventor based in Indianapolis, IN (US). He has made significant contributions to the field of microbial metabolic pathways, holding a total of 6 patents. His work focuses on innovative processes that enhance the production of valuable compounds through genetic modifications.
Latest Patents
Stowers' latest patents include a process to prepare elongated 2-ketoacids and C-5-C10 compounds via genetic modifications to microbial metabolic pathways. This involves genetically modified LeuCD' enzyme complexes, which are crucial for preparing C-C2-ketoacids. The microbial organisms that include these modified LeuCD enzyme complexes can be particularly useful for producing C-Caldehydes, alkanes, alcohols, and carboxylic acids, both in vivo and in vitro. Additionally, he has developed new strains of Propionibacterium for the biosynthetic production of propionic acid, showcasing his innovative approach to microbial applications.
Career Highlights
Throughout his career, Stowers has worked with notable organizations such as Dow Global Technologies LLC and The University of Queensland. His experience in these institutions has allowed him to advance his research and contribute to the scientific community significantly.
Collaborations
Stowers has collaborated with several professionals in his field, including Brandon A Rodriguez and Paresh C Sanghani. These collaborations have further enriched his research and innovation efforts.
Conclusion
Christopher C Stowers is a distinguished inventor whose work in microbial metabolic pathways has led to significant advancements in the production of valuable compounds. His innovative patents and collaborations highlight his commitment to scientific progress and innovation.